Skip to main content
Clinical Trials/NCT04403425
NCT04403425UnknownNot Applicable

Correlation of Central and Peripheral Measures of Tissue Perfusion During Emergency Laparotomy - a Pilot Study

Copenhagen University Hospital, Hvidovre1 site in 1 country20 target enrollmentStarted: December 25, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Preload dependency

Study Overview

Brief Summary

This study is investigating the effect of intraoperative Noradrenaline on cardiac preload and stroke volume, after initial fluid resuscitation, in order to assess whether there is a masked preload responsiveness and ultimately whether the correction of this potential preload-responsiveness with fluid therapy will translate into increased tissue perfusion in emergency laparotomy.

Detailed Description

Early detection and treatment of insufficient tissue perfusion and oxygenation is the main purpose of perioperative haemodynamic monitoring and management. Hypovolemia, septicaemia, and low flow states affecting central and peripheral perfusion are frequent in patients undergoing emergency laparotomy.

This study aims to assess the effects of Noradrenaline (NA) on cardiac preload, and tissue perfusion in patients undergoing emergency laparotomy, to investigate potential macro/microcirculatory uncoupling.

A single-centre, prospective interventional non-blinded single-arm study at the Department of Anaesthesiology and Intensive care Unit, Copenhagen University Hospital Hvidovre, Denmark. We will include patients undergoing emergency laparotomy. The study start is January 2021. After informed consent, patients will be included if they have an intraoperative need for Noradrenaline infusion >0.1 mcg/kg/min to maintain MAP ≥65 mmHg after resuscitation with a goal-directed fluid therapy algorithm. 20 patients will be included.

Intervention: At a steady state (MAP ≥65 mmHg) during the surgical procedure, we will reduce NA to investigate whether patients will be preload responsive while maintaining MAP > 50 mmHg and limiting stroke volume reduction to no more than 30%. After a subsequent fluid challenge, we will increase the dose of NA to re-establish a MAP ≥65 mmHg. In addition, peripheral and central perfusion indices, including gut perfusion, will be measured.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults (18 years or over) undergoing emergency laparotomy/laparoscopy for following abdominal pathology:
  • Perforated viscus
  • Intestinal obstruction
  • Emergency re-operations after elective surgery owing to paralytic/obstructive ileus, anastomotic leakage
  • Provided verbal and written informed consent
  • Must speak and understand the Danish language
  • Intraoperative indication for Norepinephrine infusion

Exclusion Criteria

  • Appendectomies, cholecystectomies, negative diagnostic laparoscopies/laparotomies, herniotomies without bowel resections, sub-acute internal hernias after gastric bypass surgery, sub-acute surgery for inflammatory bowel diseases.
  • Reoperation owing to fascial separation with no other abdominal pathology identified and sub-acute colorectal cancer-surgery will be excluded from the cohort. Sub-acute surgery is defined as surgery planned within 48 hours.
  • Intestinal Ischemia
  • intraabdominal bleeding
  • Traumas, gynecological, urogenital and other vascular pathology, pregnant patients.
  • Dementia and/or cognitive dysfunction (diagnosed). If the patient is not awake, alert, and oriented, times three (to person, place, and time), this also qualifies as an exclusion criterion.

Outcomes

Primary Outcomes

Preload dependency

Time Frame: intraoperatively (during general anesthesia)

the incidence of preload dependency defined as stroke volume increase of \>10% during fluid challenge after reduction of Noradrenaline.

Secondary Outcomes

  • Tissue perfusion and fluid status(intraoperatively (during general anesthesia))
  • Tissue perfusion(intraoperatively (during general anesthesia))

Investigators

Sponsor
Copenhagen University Hospital, Hvidovre
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mirjana Cihoric

MD, Research fellow

Copenhagen University Hospital, Hvidovre

Study Sites (1)

Loading locations...

Similar Trials